Cooper Companies (NASDAQ:COO) PT Raised to $116.00

Cooper Companies (NASDAQ:COOGet Free Report) had its target price boosted by equities research analysts at Citigroup from $108.00 to $116.00 in a report released on Wednesday, Benzinga reports. The firm currently has a “buy” rating on the medical device company’s stock. Citigroup’s price objective would indicate a potential upside of 17.47% from the company’s current price.

Other equities analysts have also recently issued research reports about the company. Piper Sandler raised their price target on Cooper Companies from $110.00 to $115.00 and gave the company an “overweight” rating in a report on Friday, March 1st. KeyCorp started coverage on Cooper Companies in a report on Tuesday, February 6th. They set a “sector weight” rating for the company. Mizuho lifted their target price on Cooper Companies from $102.50 to $115.00 and gave the stock a “buy” rating in a report on Friday, March 1st. JPMorgan Chase & Co. upgraded Cooper Companies from a “neutral” rating to an “overweight” rating and lifted their target price for the stock from $100.00 to $120.00 in a report on Wednesday, March 13th. Finally, TheStreet cut Cooper Companies from a “b-” rating to a “c” rating in a report on Thursday, February 29th. Three equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $109.48.

View Our Latest Report on Cooper Companies

Cooper Companies Stock Up 0.7 %

Cooper Companies stock traded up $0.69 during mid-day trading on Wednesday, hitting $98.75. The company had a trading volume of 159,310 shares, compared to its average volume of 1,095,740. The company has a current ratio of 1.86, a quick ratio of 1.08 and a debt-to-equity ratio of 0.35. The stock’s 50 day moving average price is $97.51 and its two-hundred day moving average price is $89.90. Cooper Companies has a 12 month low of $75.93 and a 12 month high of $104.07. The company has a market capitalization of $19.63 billion, a PE ratio of 67.52, a price-to-earnings-growth ratio of 2.52 and a beta of 0.94.

Cooper Companies (NASDAQ:COOGet Free Report) last issued its quarterly earnings results on Thursday, February 29th. The medical device company reported $0.85 EPS for the quarter, topping analysts’ consensus estimates of $0.78 by $0.07. The business had revenue of $931.60 million during the quarter, compared to analysts’ expectations of $915.93 million. Cooper Companies had a return on equity of 8.79% and a net margin of 7.93%. The business’s quarterly revenue was up 8.5% on a year-over-year basis. During the same quarter in the prior year, the business posted $2.90 earnings per share. As a group, sell-side analysts anticipate that Cooper Companies will post 3.5 earnings per share for the current fiscal year.

Insider Buying and Selling at Cooper Companies

In other Cooper Companies news, Director Gary S. Petersmeyer sold 600 shares of Cooper Companies stock in a transaction on Thursday, January 4th. The stock was sold at an average price of $84.01, for a total transaction of $50,404.50. Following the completion of the sale, the director now directly owns 9,188 shares of the company’s stock, valued at approximately $771,860.91. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In other news, Director Gary S. Petersmeyer sold 1,000 shares of the business’s stock in a transaction on Tuesday, March 5th. The stock was sold at an average price of $103.51, for a total value of $103,510.00. Following the completion of the transaction, the director now directly owns 5,668 shares of the company’s stock, valued at approximately $586,694.68. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Gary S. Petersmeyer sold 600 shares of the business’s stock in a transaction on Thursday, January 4th. The stock was sold at an average price of $84.01, for a total value of $50,404.50. Following the completion of the transaction, the director now directly owns 9,188 shares of the company’s stock, valued at $771,860.91. The disclosure for this sale can be found here. Insiders sold a total of 56,324 shares of company stock valued at $5,675,019 in the last ninety days. Corporate insiders own 2.00% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in the stock. Cary Street Partners Investment Advisory LLC acquired a new position in Cooper Companies during the 3rd quarter valued at about $26,000. KB Financial Partners LLC acquired a new position in Cooper Companies during the 1st quarter valued at about $34,000. Clear Street Markets LLC increased its position in Cooper Companies by 93.9% during the 1st quarter. Clear Street Markets LLC now owns 95 shares of the medical device company’s stock valued at $35,000 after buying an additional 46 shares in the last quarter. Blue Trust Inc. increased its position in Cooper Companies by 54.8% during the 4th quarter. Blue Trust Inc. now owns 96 shares of the medical device company’s stock valued at $36,000 after buying an additional 34 shares in the last quarter. Finally, Lindbrook Capital LLC increased its position in Cooper Companies by 182.5% during the 4th quarter. Lindbrook Capital LLC now owns 113 shares of the medical device company’s stock valued at $43,000 after buying an additional 73 shares in the last quarter. 24.39% of the stock is owned by institutional investors.

Cooper Companies Company Profile

(Get Free Report)

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

See Also

Analyst Recommendations for Cooper Companies (NASDAQ:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.